| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 1.15e-13 | 37 | 97 | 9 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 1.50e-13 | 38 | 97 | 9 | GO:0070001 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | ZNF729 ZNF93 HIVEP1 MYNN PRDM5 ZBTB24 ZBTB49 ZNF43 ZNF382 NFKB1 ZNF85 ZNF91 ZNF107 | 5.03e-09 | 320 | 97 | 13 | GO:0001227 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | ZNF729 ZNF93 HIVEP1 MYNN PRDM5 ZBTB24 ZBTB49 ZNF43 ZNF382 NFKB1 ZNF85 ZNF91 ZNF107 | 6.28e-09 | 326 | 97 | 13 | GO:0001217 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF729 ZNF93 HIVEP1 RBBP4 ZNF254 ZNF195 ZBTB41 MYNN PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 NFKB1 ZNF85 ZNF91 ZNF107 ZNF679 | 9.55e-08 | 1244 | 97 | 22 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF729 ZNF93 HIVEP1 RBBP4 ZNF254 ZNF195 ZBTB41 MYNN PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 NFKB1 ZNF85 ZNF91 ZNF107 ZNF679 | 1.39e-07 | 1271 | 97 | 22 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF729 ZNF93 HIVEP1 TSHZ2 ZNF254 ZNF195 ZBTB41 MYNN PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 NFKB1 ZNF85 ZNF91 ZNF107 ZNF679 | 8.37e-07 | 1412 | 97 | 22 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF729 ZNF93 HIVEP1 RBBP4 ZNF254 ZNF195 ZBTB41 MYNN PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 NFKB1 ZNF85 ZNF91 ZNF107 ZNF679 | 1.45e-06 | 1459 | 97 | 22 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.78e-05 | 11 | 97 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | structural molecule activity | RPL23A ERVK-6 ERVK-7 ERVK-21 ERVK-9 RPS27L DST ERVK-8 ERVK-18 ERVK-5 MACF1 ERVK-19 ERVK-25 ERVK-24 EPB41 | 2.49e-05 | 891 | 97 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.89e-05 | 14 | 97 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 ZNF93 HIVEP1 RBBP6 ZNF195 ERVK-7 ERVK-21 ERVK-9 ZNF675 ERVK-8 ERVK-5 ERVK-19 ZNF91 ERVK-24 | 9.97e-05 | 891 | 97 | 14 | GO:0008270 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.39e-04 | 21 | 97 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 2.46e-04 | 430 | 97 | 9 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 7.66e-04 | 37 | 97 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 8.29e-04 | 38 | 97 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 METAP1 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 1.29e-03 | 654 | 97 | 10 | GO:0008233 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.45e-03 | 46 | 97 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.76e-03 | 262 | 97 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 ZNF93 HIVEP1 RBBP6 ZNF195 ERVK-7 ERVK-21 ERVK-9 ZNF675 ERVK-8 ERVK-5 ERVK-19 ZNF91 ERVK-24 | 1.77e-03 | 1189 | 97 | 14 | GO:0046914 |
| GeneOntologyMolecularFunction | lamin binding | 3.78e-03 | 19 | 97 | 2 | GO:0005521 | |
| GeneOntologyBiologicalProcess | retrotransposition | 2.57e-09 | 48 | 97 | 7 | GO:0032197 | |
| GeneOntologyBiologicalProcess | transposition | 3.46e-09 | 50 | 97 | 7 | GO:0032196 | |
| GeneOntologyBiologicalProcess | transposable element silencing | 7.44e-08 | 46 | 97 | 6 | GO:0010526 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 ERVK-7 ERVK-21 ERVK-9 CCNT1 ERVK-8 ERVK-5 ERVK-19 ERVK-24 TARBP2 ATG16L2 | 1.16e-05 | 464 | 97 | 11 | GO:0016032 |
| GeneOntologyBiologicalProcess | DNA replication | 1.65e-05 | 312 | 97 | 9 | GO:0006260 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ZNF729 ZNF93 HIVEP1 RBBP4 RBBP8 ZNF254 CGGBP1 PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF43 ZNF382 ZNF540 NFKB1 PLCB1 ZNF85 ZNF91 ZNF107 | 2.39e-05 | 1399 | 97 | 19 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ZNF729 ZNF93 HIVEP1 RBBP4 RBBP8 ZNF254 CGGBP1 PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF43 ZNF382 ZNF540 NFKB1 PLCB1 ZNF85 ZNF91 ZNF107 | 2.74e-05 | 1413 | 97 | 19 | GO:1902679 |
| GeneOntologyBiologicalProcess | DNA integration | 2.79e-05 | 13 | 97 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | ZNF729 ZNF93 HIVEP1 RBBP4 ZNF254 CGGBP1 PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF43 ZNF382 NFKB1 ZNF85 ZNF91 ZNF107 | 3.05e-05 | 1053 | 97 | 16 | GO:0000122 |
| GeneOntologyBiologicalProcess | cell-cell fusion | 5.05e-05 | 85 | 97 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 5.05e-05 | 85 | 97 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 6.30e-05 | 89 | 97 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 1.96e-04 | 178 | 97 | 6 | GO:0006261 | |
| MousePheno | decreased eosinophil cell number | 3.44e-05 | 84 | 62 | 5 | MP:0005012 | |
| MousePheno | abnormal bone marrow cell morphology/development | ZNF729 HIVEP1 GALR1 MCM3 RPS27L DST ZNF43 NFKB1 ZNF85 ZNF91 ZNF107 DNM2 | 5.28e-05 | 706 | 62 | 12 | MP:0002398 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF729 ZNF93 HIVEP1 TSHZ2 ZNF254 ZNF195 ZBTB41 MYNN GPATCH8 PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 ZFP91 ZNF85 ZNF91 ZNF839 ZNF107 ZNF679 | 9.10e-14 | 775 | 88 | 24 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF729 ZNF93 HIVEP1 TSHZ2 ZNF254 ZNF195 ZBTB41 MYNN GPATCH8 PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 ZFP91 ZNF85 ZNF91 ZNF839 ZNF107 ZNF679 | 9.63e-14 | 777 | 88 | 24 | PS00028 |
| Domain | Znf_C2H2-like | ZNF729 ZNF93 HIVEP1 TSHZ2 ZNF254 ZNF195 ZBTB41 MYNN GPATCH8 PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 ZFP91 ZNF85 ZNF91 ZNF839 ZNF107 ZNF679 | 1.63e-13 | 796 | 88 | 24 | IPR015880 |
| Domain | Znf_C2H2 | ZNF729 ZNF93 HIVEP1 TSHZ2 ZNF254 ZNF195 ZBTB41 MYNN GPATCH8 PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 ZFP91 ZNF85 ZNF91 ZNF839 ZNF107 ZNF679 | 2.07e-13 | 805 | 88 | 24 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF729 ZNF93 HIVEP1 TSHZ2 ZNF254 ZNF195 ZBTB41 MYNN GPATCH8 PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 ZFP91 ZNF85 ZNF91 ZNF839 ZNF107 ZNF679 | 2.25e-13 | 808 | 88 | 24 | SM00355 |
| Domain | zf-C2H2 | ZNF729 ZNF93 HIVEP1 TSHZ2 ZNF254 ZNF195 ZBTB41 MYNN PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 ZFP91 ZNF85 ZNF91 ZNF107 ZNF679 | 7.33e-13 | 693 | 88 | 22 | PF00096 |
| Domain | zf-C2H2_6 | ZNF729 ZNF93 ZNF195 ZBTB41 MYNN PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF836 ZNF43 ZNF382 ZNF540 ZNF85 ZNF91 ZNF107 | 1.35e-12 | 314 | 88 | 16 | PF13912 |
| Domain | - | ZNF729 ZNF93 HIVEP1 ZNF254 ZNF195 ZBTB41 MYNN PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 ZFP91 ZNF85 ZNF91 ZNF107 ZNF679 | 4.40e-12 | 679 | 88 | 21 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF729 ZNF93 HIVEP1 ZNF254 ZNF195 ZBTB41 MYNN PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 ZFP91 ZNF85 ZNF91 ZNF107 ZNF679 | 6.65e-12 | 694 | 88 | 21 | IPR013087 |
| Domain | KRAB | ZNF729 ZNF93 ZNF254 ZNF195 ZNF675 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 ZNF85 ZNF91 ZNF679 | 1.25e-08 | 358 | 88 | 13 | PS50805 |
| Domain | KRAB | ZNF729 ZNF93 ZNF254 ZNF195 ZNF675 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 ZNF85 ZNF91 ZNF679 | 1.25e-08 | 358 | 88 | 13 | PF01352 |
| Domain | KRAB | ZNF729 ZNF93 ZNF254 ZNF195 ZNF675 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 ZNF85 ZNF91 ZNF679 | 1.79e-08 | 369 | 88 | 13 | SM00349 |
| Domain | KRAB | ZNF729 ZNF93 ZNF254 ZNF195 ZNF675 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 ZNF85 ZNF91 ZNF679 | 1.84e-08 | 370 | 88 | 13 | IPR001909 |
| Domain | Actinin_actin-bd_CS | 3.80e-06 | 23 | 88 | 4 | IPR001589 | |
| Domain | ACTININ_2 | 3.80e-06 | 23 | 88 | 4 | PS00020 | |
| Domain | ACTININ_1 | 3.80e-06 | 23 | 88 | 4 | PS00019 | |
| Domain | Spectrin | 1.67e-04 | 23 | 88 | 3 | PF00435 | |
| Domain | zf-CCHC | 1.67e-04 | 23 | 88 | 3 | PF00098 | |
| Domain | CH | 2.50e-04 | 65 | 88 | 4 | SM00033 | |
| Domain | - | 3.25e-04 | 6 | 88 | 2 | 3.90.1290.10 | |
| Domain | GAR | 3.25e-04 | 6 | 88 | 2 | PS51460 | |
| Domain | - | 3.25e-04 | 6 | 88 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 3.25e-04 | 6 | 88 | 2 | IPR003108 | |
| Domain | GAS2 | 3.25e-04 | 6 | 88 | 2 | PF02187 | |
| Domain | GAS2 | 3.25e-04 | 6 | 88 | 2 | SM00243 | |
| Domain | CH | 3.33e-04 | 70 | 88 | 4 | PF00307 | |
| Domain | Spectrin_repeat | 3.38e-04 | 29 | 88 | 3 | IPR002017 | |
| Domain | - | 3.51e-04 | 71 | 88 | 4 | 1.10.418.10 | |
| Domain | CH | 3.91e-04 | 73 | 88 | 4 | PS50021 | |
| Domain | CH-domain | 4.33e-04 | 75 | 88 | 4 | IPR001715 | |
| Domain | Plectin_repeat | 4.54e-04 | 7 | 88 | 2 | IPR001101 | |
| Domain | Plectin | 4.54e-04 | 7 | 88 | 2 | PF00681 | |
| Domain | PLEC | 4.54e-04 | 7 | 88 | 2 | SM00250 | |
| Domain | Spectrin/alpha-actinin | 4.54e-04 | 32 | 88 | 3 | IPR018159 | |
| Domain | SPEC | 4.54e-04 | 32 | 88 | 3 | SM00150 | |
| Domain | ZF_CCHC | 5.93e-04 | 35 | 88 | 3 | PS50158 | |
| Domain | I-BAR_dom | 1.66e-03 | 13 | 88 | 2 | IPR013606 | |
| Domain | ZnF_C2HC | 2.22e-03 | 55 | 88 | 3 | SM00343 | |
| Domain | Znf_CCHC | 2.22e-03 | 55 | 88 | 3 | IPR001878 | |
| Domain | BTB | 3.42e-03 | 131 | 88 | 4 | PF00651 | |
| Domain | BAR | 3.56e-03 | 19 | 88 | 2 | PS51021 | |
| Domain | Znf_C2H2_jaz | 4.77e-03 | 22 | 88 | 2 | IPR022755 | |
| Domain | zf-C2H2_jaz | 4.77e-03 | 22 | 88 | 2 | PF12171 | |
| Domain | G_patch | 5.21e-03 | 23 | 88 | 2 | SM00443 | |
| Domain | G_patch_dom | 5.21e-03 | 23 | 88 | 2 | IPR000467 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | ZNF729 ZNF93 RBBP4 RBBP8 ZNF254 ZNF195 TTF1 CCNT1 ZNF836 ZNF43 ZNF382 MLLT3 BOD1L1 ZNF85 ZNF91 ZNF839 ZNF107 TARBP2 | 2.29e-07 | 1022 | 62 | 18 | MM15436 |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | ZNF729 ZNF93 RBBP4 RBBP8 ZNF254 ZNF195 CCNT1 ZNF836 ZNF43 ZNF382 ZNF85 ZNF91 ZNF839 ZNF107 | 4.55e-06 | 768 | 62 | 14 | MM14851 |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 2.85e-05 | 136 | 62 | 6 | MM14848 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 1.05e-04 | 56 | 62 | 4 | MM17236 | |
| Pubmed | ZNF729 ZNF93 ZNF254 ZNF195 ZNF716 ZNF43 ZNF85 ZNF91 ZNF107 ZNF679 | 4.19e-19 | 29 | 99 | 10 | 14563677 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 ERVK-5 ERVK-19 ERVK-25 ERVK-24 | 1.63e-13 | 94 | 99 | 10 | 21542922 |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.69e-13 | 5 | 99 | 5 | 12629516 | |
| Pubmed | 2.24e-12 | 15 | 99 | 6 | 15885501 | ||
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 9.51e-11 | 49 | 99 | 7 | 9630514 | |
| Pubmed | 1.32e-10 | 12 | 99 | 5 | 14557543 | ||
| Pubmed | 7.19e-10 | 16 | 99 | 5 | 8467795 | ||
| Pubmed | ZNF729 ZNF93 HIVEP1 HMGXB4 ZNF254 ZNF195 ZBTB41 MYNN PRDM5 ZBTB24 ZNF836 ZNF716 ZNF43 NFKB1 ZNF91 ZNF679 | 1.17e-09 | 808 | 99 | 16 | 20412781 | |
| Pubmed | 1.40e-09 | 18 | 99 | 5 | 18664271 | ||
| Pubmed | 4.29e-09 | 8 | 99 | 4 | 2023909 | ||
| Pubmed | Functional analysis of the SRY-KRAB interaction in mouse sex determination. | 1.28e-08 | 10 | 99 | 4 | 18588511 | |
| Pubmed | Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein. | 2.01e-08 | 11 | 99 | 4 | 15469996 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 10516026 | ||
| Pubmed | RBBP6 ARHGAP10 SYNE1 HMGXB4 GPATCH8 CGGBP1 TTF1 CTTNBP2NL RPS27L METAP1 CCNT1 DST RBMX2 ZFP91 MACF1 FKBP8 TARBP2 EPB41 GOLGB1 | 3.97e-08 | 1497 | 99 | 19 | 31527615 | |
| Pubmed | 4.33e-08 | 13 | 99 | 4 | 19850934 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 8.93e-08 | 4 | 99 | 3 | 10469592 | |
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 7983737 | ||
| Pubmed | HIVEP1 RBBP6 PPIL4 L1TD1 TTF1 ZNF675 METAP1 DST MACF1 ZNF107 GOLGB1 DNM2 | 1.25e-07 | 591 | 99 | 12 | 15231748 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 2.23e-07 | 5 | 99 | 3 | 11401426 | |
| Pubmed | 4.45e-07 | 6 | 99 | 3 | 15063128 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HIVEP1 RBBP4 RBBP6 HMGXB4 PPIL4 MCM3 RPS27L METAP1 CCNT1 SLF2 SAFB2 BOD1L1 HSPA2 EPB41 | 5.43e-07 | 954 | 99 | 14 | 36373674 |
| Pubmed | 1.86e-06 | 9 | 99 | 3 | 10360839 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RPL23A RBBP4 RBBP6 SYNE1 HMGXB4 PPIL4 MCM3 GPATCH8 CGGBP1 RPS27L DST RBMX2 SAFB2 MACF1 | 2.38e-06 | 1082 | 99 | 14 | 38697112 |
| Pubmed | ZNF93 ZNF254 ZBTB41 GPATCH8 ZBTB24 KIAA0753 TAOK3 CLMN SAFB2 MACF1 BOD1L1 ANKRD12 GOLGB1 DNM2 | 2.43e-06 | 1084 | 99 | 14 | 11544199 | |
| Pubmed | 2.65e-06 | 10 | 99 | 3 | 12970426 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 11002341 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 8.02e-06 | 2 | 99 | 2 | 9460924 | |
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 8.02e-06 | 2 | 99 | 2 | 11672541 | |
| Pubmed | 1.07e-05 | 486 | 99 | 9 | 20936779 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | HIVEP1 RBBP6 RBBP8 MCM3 GPATCH8 ECPAS CTTNBP2NL RBMX2 ZFP91 SAFB2 DNM2 | 1.32e-05 | 774 | 99 | 11 | 15302935 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RBBP6 CCNT1 DST ALMS1 CLMN SAFB2 MACF1 BOD1L1 EPB41 GOLGB1 HERC5 DNM2 | 1.42e-05 | 934 | 99 | 12 | 33916271 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPL23A RBBP6 SYNE1 MCM3 RPS27L DST RBMX2 ZFP91 SAFB2 HSPA2 EPB41 HERC5 | 1.67e-05 | 949 | 99 | 12 | 36574265 |
| Pubmed | RBBP4 RBBP6 ARHGAP10 HMGXB4 L1TD1 PRDM5 CCNT1 ALMS1 ZNF43 ZFP91 MACF1 FKBP8 TARBP2 | 1.72e-05 | 1116 | 99 | 13 | 31753913 | |
| Pubmed | 1.76e-05 | 284 | 99 | 7 | 15057824 | ||
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 2.02e-05 | 56 | 99 | 4 | 26919559 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TSHZ2 RBBP4 ARHGAP10 ECPAS TTF1 CLMN GCC2 MACF1 RASSF3 BOD1L1 ANKRD12 ZNF839 ZNF107 EPB41 GOLGB1 | 2.03e-05 | 1489 | 99 | 15 | 28611215 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 2.34e-05 | 410 | 99 | 8 | 26949251 | |
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 2.40e-05 | 3 | 99 | 2 | 12399109 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 8838817 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 9971820 | ||
| Pubmed | A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients. | 2.40e-05 | 3 | 99 | 2 | 33150179 | |
| Pubmed | An evolutionary arms race between KRAB zinc-finger genes ZNF91/93 and SVA/L1 retrotransposons. | 2.40e-05 | 3 | 99 | 2 | 25274305 | |
| Pubmed | 2.46e-05 | 20 | 99 | 3 | 21689717 | ||
| Pubmed | 2.46e-05 | 20 | 99 | 3 | 7479878 | ||
| Pubmed | 2.46e-05 | 20 | 99 | 3 | 2542606 | ||
| Pubmed | 2.66e-05 | 60 | 99 | 4 | 20682791 | ||
| Pubmed | 2.69e-05 | 418 | 99 | 8 | 34709266 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | RBBP4 RBBP6 MCM3 GPATCH8 METAP1 TAOK3 RBMX2 SAFB2 ATG16L2 DNM2 | 3.23e-05 | 701 | 99 | 10 | 30196744 |
| Pubmed | 3.23e-05 | 63 | 99 | 4 | 34351428 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HIVEP1 TMCC3 KIAA0753 DST ALMS1 SLF2 CLMN MACF1 BOD1L1 EPB41 GOLGB1 | 3.49e-05 | 861 | 99 | 11 | 36931259 |
| Pubmed | 3.92e-05 | 441 | 99 | 8 | 31239290 | ||
| Pubmed | 4.59e-05 | 451 | 99 | 8 | 36168627 | ||
| Pubmed | 4.65e-05 | 225 | 99 | 6 | 12168954 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 4.76e-05 | 588 | 99 | 9 | 38580884 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 20171262 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 8954775 | ||
| Pubmed | The role of Dicer protein partners in the processing of microRNA precursors. | 4.79e-05 | 4 | 99 | 2 | 22163034 | |
| Pubmed | Acetylation of cyclin T1 regulates the equilibrium between active and inactive P-TEFb in cells. | 4.79e-05 | 4 | 99 | 2 | 19387490 | |
| Pubmed | RPL23A RBBP8 SYNE1 ZBTB41 MYNN ZNF675 DST RBMX2 SAFB2 ANKRD30A MACF1 BOD1L1 HSPA2 GOLGB1 | 5.87e-05 | 1442 | 99 | 14 | 35575683 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 6.16e-05 | 608 | 99 | 9 | 36089195 | |
| Pubmed | 6.31e-05 | 472 | 99 | 8 | 38943005 | ||
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 24190968 | ||
| Pubmed | Differential regulation of NF-kappaB by elongation factors is determined by core promoter type. | 7.98e-05 | 5 | 99 | 2 | 17502349 | |
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 18203956 | ||
| Pubmed | A pair of mouse KRAB zinc finger proteins modulates multiple indicators of female reproduction. | 7.98e-05 | 5 | 99 | 2 | 20042539 | |
| Pubmed | 8.51e-05 | 251 | 99 | 6 | 31076518 | ||
| Pubmed | 9.03e-05 | 497 | 99 | 8 | 23414517 | ||
| Pubmed | 9.49e-05 | 31 | 99 | 3 | 26678539 | ||
| Pubmed | 1.06e-04 | 653 | 99 | 9 | 33742100 | ||
| Pubmed | 1.06e-04 | 653 | 99 | 9 | 22586326 | ||
| Pubmed | The human genome contains hundreds of genes coding for finger proteins of the Krüppel type. | 1.19e-04 | 6 | 99 | 2 | 2505992 | |
| Pubmed | The KRAB-zinc-finger protein ZFP708 mediates epigenetic repression at RMER19B retrotransposons. | 1.19e-04 | 6 | 99 | 2 | 30846446 | |
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 21896721 | ||
| Pubmed | HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP. | 1.26e-04 | 34 | 99 | 3 | 25925205 | |
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 1.64e-04 | 283 | 99 | 6 | 28533407 | |
| Pubmed | 1.67e-04 | 7 | 99 | 2 | 22801370 | ||
| Pubmed | 2.02e-04 | 187 | 99 | 5 | 26460568 | ||
| Pubmed | 2.04e-04 | 101 | 99 | 4 | 9872452 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 2.06e-04 | 714 | 99 | 9 | 28302793 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 2.42e-04 | 432 | 99 | 7 | 23455922 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.58e-04 | 197 | 99 | 5 | 20811636 | |
| Pubmed | 2.85e-04 | 9 | 99 | 2 | 24565118 | ||
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 2.91e-04 | 315 | 99 | 6 | 26777405 | |
| Pubmed | 3.56e-04 | 10 | 99 | 2 | 20153263 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RPL23A RBBP4 RBBP6 MCM3 TTF1 RPS27L METAP1 CCNT1 TAOK3 RBMX2 SAFB2 DNM2 | 3.69e-04 | 1318 | 99 | 12 | 30463901 |
| Pubmed | 3.82e-04 | 119 | 99 | 4 | 23508102 | ||
| Pubmed | 3.85e-04 | 215 | 99 | 5 | 35973513 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 3.94e-04 | 120 | 99 | 4 | 31413325 | |
| Pubmed | 4.04e-04 | 335 | 99 | 6 | 15741177 | ||
| Pubmed | 4.34e-04 | 11 | 99 | 2 | 20694014 | ||
| Pubmed | 4.34e-04 | 11 | 99 | 2 | 11704662 | ||
| Pubmed | The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. | 4.34e-04 | 11 | 99 | 2 | 16815997 | |
| Pubmed | 4.34e-04 | 11 | 99 | 2 | 20471949 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 4.43e-04 | 341 | 99 | 6 | 32971831 | |
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 4.83e-04 | 226 | 99 | 5 | 25900982 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 5.03e-04 | 807 | 99 | 9 | 30575818 | |
| Pubmed | Functions of Tat: the versatile protein of human immunodeficiency virus type 1. | 5.20e-04 | 12 | 99 | 2 | 19812265 | |
| Pubmed | 5.27e-04 | 55 | 99 | 3 | 29997285 | ||
| Pubmed | 5.65e-04 | 234 | 99 | 5 | 36243803 | ||
| Cytoband | 19p12 | 1.05e-09 | 90 | 98 | 7 | 19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 8.90e-09 | 122 | 98 | 7 | chr19p12 | |
| Cytoband | 11q22.1 | 4.04e-04 | 14 | 98 | 2 | 11q22.1 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF729 ZNF93 HIVEP1 TSHZ2 ZNF254 ZNF195 ZBTB41 MYNN PRDM5 ZBTB24 ZNF675 ZBTB49 ZNF836 ZNF716 ZNF43 ZNF382 ZNF540 ZFP91 ZNF85 ZNF91 ZNF107 ZNF679 | 1.24e-15 | 718 | 63 | 22 | 28 |
| GeneFamily | EF-hand domain containing|Plakins | 3.30e-04 | 8 | 63 | 2 | 939 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.23e-03 | 134 | 63 | 4 | 861 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 3.14e-03 | 24 | 63 | 2 | 654 | |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_UP | 1.25e-06 | 102 | 88 | 6 | MM749 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ARHGAP10 RBBP8 PPIL4 L1TD1 ZNF195 ARFGEF1 TAOK3 ZNF43 GCC2 ZNF85 ZNF107 GOLGB1 | 1.98e-06 | 656 | 88 | 12 | M18979 |
| Coexpression | DE_YY1_TARGETS_DN | 1.57e-05 | 93 | 88 | 5 | M3278 | |
| Coexpression | YAGI_AML_WITH_T_8_21_TRANSLOCATION | 3.65e-05 | 372 | 88 | 8 | M19261 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K4ME3 | 4.47e-05 | 497 | 88 | 9 | MM863 | |
| Coexpression | DURAND_STROMA_NS_UP | 4.98e-05 | 194 | 88 | 6 | MM962 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN | 5.90e-05 | 200 | 88 | 6 | M9341 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | ZNF729 ZNF93 ZNF254 MYNN RBM48 ZNF43 ZFP91 SAFB2 ZNF91 ZNF107 | 8.90e-05 | 675 | 88 | 10 | MM1073 |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 9.42e-05 | 426 | 88 | 8 | M9516 | |
| Coexpression | TERAO_AOX4_TARGETS_SKIN_DN | 1.13e-04 | 28 | 88 | 3 | MM925 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 8.83e-07 | 186 | 86 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | SYNE1 ARFGEF1 ECPAS CTTNBP2NL SLF2 GCC2 MACF1 BOD1L1 GOLGB1 ATG16L2 MAP3K19 | 1.35e-06 | 432 | 86 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | TSHZ2 RBBP8 PPIL4 CTTNBP2NL ALMS1 SLF2 GCC2 MACF1 BOD1L1 EPB41 MAP3K19 | 4.72e-06 | 492 | 86 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | TSHZ2 RBBP8 SYNE1 CTTNBP2NL SLF2 GCC2 MACF1 MLLT3 BOD1L1 ANKRD12 EPB41 MAP3K19 | 1.32e-04 | 834 | 86 | 12 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ZNF729 ARHGAP42 ZNF93 RBBP8 PRDM5 CTTNBP2NL KIAA0753 ALMS1 ZNF43 GCC2 MLLT3 BOD1L1 ANKRD12 ZNF91 EPB41 | 1.39e-04 | 1252 | 86 | 15 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | TSHZ2 RBBP8 PPIL4 CTTNBP2NL ALMS1 SLF2 ZNF43 GCC2 PLCB1 MACF1 BOD1L1 EPB41 MAP3K19 | 1.49e-04 | 978 | 86 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.67e-04 | 201 | 86 | 6 | gudmap_developingKidney_e15.5_500_k3 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.41e-07 | 197 | 89 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.51e-07 | 199 | 89 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.51e-07 | 199 | 89 | 7 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.56e-07 | 200 | 89 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.01e-06 | 186 | 89 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.14e-06 | 188 | 89 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-06 | 191 | 89 | 6 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-06 | 195 | 89 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-06 | 195 | 89 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.81e-06 | 197 | 89 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.97e-06 | 199 | 89 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 2.97e-06 | 199 | 89 | 6 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.06e-06 | 200 | 89 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 8.52e-06 | 138 | 89 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.28e-05 | 150 | 89 | 5 | 1aa9320d97ff10994ea024751790524fe133aba9 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.32e-05 | 151 | 89 | 5 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.40e-05 | 171 | 89 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | COPD-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 2.54e-05 | 173 | 89 | 5 | 4a0043b29f8ede5a74bdb38cbf2c70e12b25e130 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.75e-05 | 176 | 89 | 5 | d5cee483d2a60f82fdc67ad447b589d022fe8c97 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-progenitor-Germ|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.75e-05 | 176 | 89 | 5 | eea554ea75580f8dd5fefb57e7f33441ab86b884 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tnaive/CM_CD4|GI_large-bowel / Manually curated celltypes from each tissue | 2.83e-05 | 177 | 89 | 5 | eb87ea93e36a8f97442ec8515f658ee61932dc0f | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 3.15e-05 | 181 | 89 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 184 | 89 | 5 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.77e-05 | 188 | 89 | 5 | e5c480b9a030536578f1cc91fb61738f752525b3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-05 | 189 | 89 | 5 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.07e-05 | 191 | 89 | 5 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.07e-05 | 191 | 89 | 5 | c5e22df4a8741b8096cdd1618271fd48d6265846 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.07e-05 | 191 | 89 | 5 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.17e-05 | 192 | 89 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 192 | 89 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 4.27e-05 | 193 | 89 | 5 | 024d30eb143d8278c0851c3a6c9426226fa3b480 | |
| ToppCell | severe_COVID-19-CD4+_T_naive|severe_COVID-19 / disease group, cell group and cell class (v2) | 4.38e-05 | 194 | 89 | 5 | 4b86f3cc173ea779399d5b3598b45b25f60a4395 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.49e-05 | 195 | 89 | 5 | 07035a5972a78b98e4ab2167e3a5000f9f3b0826 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.49e-05 | 195 | 89 | 5 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.49e-05 | 195 | 89 | 5 | 5001e68df2ad5df9dc93ae235f984ffafea6b521 | |
| ToppCell | COVID-19_Moderate-CD4+_T_naive|World / disease group, cell group and cell class | 4.49e-05 | 195 | 89 | 5 | 38d65cf0895f7a99d789ec3dcbd56a7506706d38 | |
| ToppCell | COVID-19_Severe-CD4+_T_activated|World / disease group, cell group and cell class | 4.49e-05 | 195 | 89 | 5 | 61d2d6c2d59799b3d877e622ccbcee9e84703a35 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.49e-05 | 195 | 89 | 5 | 53528e5788083bce5a8d4611ab3808878e6a9cd3 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.49e-05 | 195 | 89 | 5 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.60e-05 | 196 | 89 | 5 | 37a5f9f3988778655580bd0383811bb4930c1551 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.60e-05 | 196 | 89 | 5 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.71e-05 | 197 | 89 | 5 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 4.71e-05 | 197 | 89 | 5 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.83e-05 | 198 | 89 | 5 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.83e-05 | 198 | 89 | 5 | 72aad5b2dcd8b0bde58828fa4f8129fe6cb6a21d | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 4.83e-05 | 198 | 89 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 4.94e-05 | 199 | 89 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 4.94e-05 | 199 | 89 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 4.94e-05 | 199 | 89 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.94e-05 | 199 | 89 | 5 | 3e4baaf4ee23f257d821194468102c00a8ad2f21 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.94e-05 | 199 | 89 | 5 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.94e-05 | 199 | 89 | 5 | f3cc3cda38f78d1d12d865df339d93c5fecf19f2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.94e-05 | 199 | 89 | 5 | c3c73c9404a73133bfad1f9ced292f5e508ef767 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 4.94e-05 | 199 | 89 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-05 | 200 | 89 | 5 | d70bad979299615fcba707ba21296020918705e6 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-05 | 200 | 89 | 5 | 38c21ec379005f688df33aea65237a063c476c2e | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.24e-05 | 118 | 89 | 4 | c351e465ece4f3767b2c19e695eca3c263c68777 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.55e-04 | 135 | 89 | 4 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.55e-04 | 135 | 89 | 4 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.39e-04 | 151 | 89 | 4 | 0cc2f4aec3dae4603fa831f22c40f897e68b34e2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.39e-04 | 151 | 89 | 4 | b545823113a3450c5f841f7de48bf0937593544f | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 2.77e-04 | 157 | 89 | 4 | 23879e65a6acc33d9aad096cd23604a77b0ac9c2 | |
| ToppCell | severe-CD4+_T_naive|World / disease stage, cell group and cell class | 2.77e-04 | 157 | 89 | 4 | ccf9abe0b59e9ea728cec4bba1872ffe14c7385c | |
| ToppCell | Control-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 3.58e-04 | 168 | 89 | 4 | d7118d39253ed9790908b850088ebfc5a86f4065 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.82e-04 | 171 | 89 | 4 | 2991096336eea87740708360e34f84a00cb2eff2 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.91e-04 | 172 | 89 | 4 | 9497948bbe53fb88c6ff6b347f743d456da587e5 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 172 | 89 | 4 | 7295bf3ae21a61dd6bcfa0dfb7a37d0f3e8f94ab | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.17e-04 | 175 | 89 | 4 | 2fbffcb843f364645b99d1211698d96092abc5ef | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-stromal_related-Germ|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.17e-04 | 175 | 89 | 4 | d0d5ae2a9357aa183ab720c891d86b80c9822930 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.17e-04 | 175 | 89 | 4 | 87e557f7508c88b2087db5d57e77d5e2c92ca083 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.36e-04 | 177 | 89 | 4 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.36e-04 | 177 | 89 | 4 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | wk_15-18-Hematologic-Myeloid-aDC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.36e-04 | 177 | 89 | 4 | ccf5dc54780d6039a4d062dee88440c011ddc0a3 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-04 | 177 | 89 | 4 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 4.36e-04 | 177 | 89 | 4 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.36e-04 | 177 | 89 | 4 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.36e-04 | 177 | 89 | 4 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.36e-04 | 177 | 89 | 4 | db6de487ef7976b444afadbf3ac60b3259925566 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.36e-04 | 177 | 89 | 4 | d34b086a5931d7f1737a504952d51c47693e91a8 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.36e-04 | 177 | 89 | 4 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.45e-04 | 178 | 89 | 4 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 178 | 89 | 4 | 6c1b5087581ca8cea976d89ea6f34088c8fc3668 | |
| ToppCell | normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.45e-04 | 178 | 89 | 4 | fa3585383a1e7da460c88a802aaa81246d681b6b | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 4.54e-04 | 179 | 89 | 4 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.54e-04 | 179 | 89 | 4 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.74e-04 | 181 | 89 | 4 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.74e-04 | 181 | 89 | 4 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | PBMC-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 4.84e-04 | 182 | 89 | 4 | 4774066d0f9986abc3d13a2a3bc99ce4f1327ae0 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 4.94e-04 | 183 | 89 | 4 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 4.94e-04 | 183 | 89 | 4 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.94e-04 | 183 | 89 | 4 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-04 | 184 | 89 | 4 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.14e-04 | 185 | 89 | 4 | 406b52516b26e9fe2c9e768950af447ec7ad5f3e | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.14e-04 | 185 | 89 | 4 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 185 | 89 | 4 | 512a195ebbae445afe3722a3943020080daf2f3c | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 5.14e-04 | 185 | 89 | 4 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.14e-04 | 185 | 89 | 4 | f2ebd099c8dfcfaca4298bcdd618c50701a9c2c8 | |
| ToppCell | normal_Lung-Myeloid_cells-Activated_DCs|normal_Lung / Location, Cell class and cell subclass | 5.25e-04 | 186 | 89 | 4 | 0987c9a39503eb6c75a2bf4db98b2b2fd46956fb | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.25e-04 | 186 | 89 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4|Lung / Manually curated celltypes from each tissue | 5.25e-04 | 186 | 89 | 4 | c67f373ba60e8d1ab70dfacc711ee440eaff6fb3 | |
| Computational | Genes in the cancer module 197. | 1.87e-05 | 174 | 52 | 7 | MODULE_197 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.78e-05 | 49 | 52 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.51e-05 | 50 | 52 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Computational | Genes in the cancer module 98. | 9.71e-05 | 393 | 52 | 9 | MODULE_98 | |
| Computational | Testis genes. | 1.09e-04 | 310 | 52 | 8 | MODULE_72 | |
| Computational | Genes in the cancer module 123. | 1.72e-04 | 247 | 52 | 7 | MODULE_123 | |
| Drug | Ellipticine [519-23-3]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 7.14e-07 | 187 | 89 | 8 | 2758_DN | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.19e-05 | 196 | 89 | 7 | 5521_DN | |
| Drug | Naringin hydrate [11032-30-7]; Down 200; 6.6uM; HL60; HT_HG-U133A | 1.28e-05 | 198 | 89 | 7 | 2425_DN | |
| Disease | X-linked mental retardation with cerebellar hypoplasia and distinctive facial appearance (implicated_via_orthology) | 4.79e-05 | 4 | 84 | 2 | DOID:0080311 (implicated_via_orthology) | |
| Disease | mastiha supplement exposure measurement, blood glutathione peroxidase measurement | 7.96e-05 | 5 | 84 | 2 | EFO_0600067, EFO_0600071 | |
| Disease | verbal memory measurement | 1.67e-04 | 7 | 84 | 2 | EFO_0009591 | |
| Disease | beta-Ala-His dipeptidase measurement | 2.22e-04 | 8 | 84 | 2 | EFO_0008033 | |
| Disease | attempted suicide, mood disorder | 2.22e-04 | 8 | 84 | 2 | EFO_0004247, EFO_0004321 | |
| Disease | pro‐interleukin‐16 measurement | 4.33e-04 | 11 | 84 | 2 | EFO_0010629 | |
| Disease | phosphoglyceric acid measurement | 1.06e-03 | 17 | 84 | 2 | EFO_0010523 | |
| Disease | theta wave measurement | 1.06e-03 | 17 | 84 | 2 | EFO_0006873 | |
| Disease | forced expiratory volume | 1.84e-03 | 789 | 84 | 8 | EFO_0004314 | |
| Disease | hematocrit | HIVEP1 ARHGAP10 TMCC3 PLCB1 MLLT3 RASSF3 FKBP8 MAP3K19 TDRD12 | 2.32e-03 | 1011 | 84 | 9 | EFO_0004348 |
| Disease | blood cadmium measurement | 2.49e-03 | 26 | 84 | 2 | EFO_0007576 | |
| Disease | putamen volume change measurement, age at assessment | 2.68e-03 | 27 | 84 | 2 | EFO_0008007, EFO_0021495 | |
| Disease | DNA methylation | 2.69e-03 | 656 | 84 | 7 | GO_0006306 | |
| Disease | upper face morphology measurement | 2.71e-03 | 97 | 84 | 3 | EFO_0010949 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RSKHKKHKHSSEEDK | 51 | Q13523 | |
| HTPVSDKKKKKCSIH | 11 | Q15361 | |
| KKIVKDLEASHQHSS | 271 | Q9P2B4 | |
| EEIKKHHASISELKK | 676 | P11171 | |
| DSDLTESLDKHKHKK | 181 | O42043 | |
| VDSDLTESLDKHKHK | 291 | O71037 | |
| TESLDKHKHKKLQSF | 296 | O71037 | |
| VDSDLTESLDKHKHK | 291 | Q902F8 | |
| TESLDKHKHKKLQSF | 296 | Q902F8 | |
| DSDLTESLDKHKHKK | 291 | Q9UKH3 | |
| HKDKVTAAKFKLTRH | 421 | Q8NAA4 | |
| SSHLEKAHKKGSLEK | 176 | Q5JRM2 | |
| TATKKLHTHGDKQDK | 756 | Q99708 | |
| IKEKLEGKSKCLHHS | 236 | Q5JQC9 | |
| LEKILADKEVKKAHH | 16 | Q9Y6D6 | |
| KEHKEKPSKDSREHK | 201 | P42568 | |
| VKLNKSASETHHLLK | 16 | Q3ZCU0 | |
| HKNTGELKKSKVLSH | 3686 | Q8TCU4 | |
| HKKADNKSKITIDIH | 1341 | Q9BXX3 | |
| KKEAAHIKAIKDHSK | 91 | Q5T7R7 | |
| HDKHETKAENTKLKL | 296 | Q9BSW2 | |
| HLKSKTHTKRKAEFE | 61 | Q9UFW8 | |
| TKSREHKEKHKTHPS | 501 | O60563 | |
| KIKHEHKSEKDKLDL | 846 | Q6UB98 | |
| KIKEKDKLYSHHTEK | 866 | Q6UB98 | |
| HYVTKKKLVTEHKDT | 151 | Q5RL73 | |
| ELKKEKPKHEHKSSS | 241 | Q9Y388 | |
| HSYLSKEEIKEKVHK | 46 | Q86WH2 | |
| LRSHKKTHTGEKEKI | 476 | Q9NQX1 | |
| TSKKHKKKTHHCSEE | 381 | Q8WUA2 | |
| HKDEKKISLKHELFR | 531 | Q6ZRR7 | |
| KKTSSRHKKLHLGLD | 141 | Q96LL4 | |
| DKHLNLSAKKKDSHL | 146 | A1A4S6 | |
| ATHKLLHKKAKDEKA | 46 | P53582 | |
| SHKHKETLAKMEELK | 4251 | Q03001 | |
| RKLSTHKEVKSHLKE | 971 | Q5VYK3 | |
| KHKRKHKADTEEKSS | 686 | Q9UKJ3 | |
| VSHLAEEFKRKHKKD | 241 | P54652 | |
| KHKTKVHSGADKTLD | 516 | Q9NPC7 | |
| FTKLSLHEKKTHTAK | 16 | Q05C16 | |
| LHEKKTHTAKTGKIE | 21 | Q05C16 | |
| LHTDGHSEKKKKKEE | 381 | Q9UGU5 | |
| SKTEHAEFLHCKSKK | 76 | P50570 | |
| VDSDLTESLDKHKHK | 1051 | P63135 | |
| TESLDKHKHKKLQSF | 1056 | P63135 | |
| FLAKHGHKLSEKEKK | 1491 | Q9UPN3 | |
| LKLKLHSFESHKDEI | 306 | Q09028 | |
| KHKKHAGTEVELEKS | 1746 | Q7Z6E9 | |
| HTDTLLKIESKKHKA | 646 | Q9UII4 | |
| EKHDNLLHGTKKKKE | 546 | P25205 | |
| HCEKEKISSSKELKH | 606 | Q8NFC6 | |
| KISSSKELKHVHAKS | 611 | Q8NFC6 | |
| KHLKKDDSETPHLKS | 701 | Q8NFC6 | |
| HIRKDSHLSDTKESK | 321 | P47211 | |
| TIHAELSKLVKKHAA | 341 | Q14318 | |
| AKIGSDLKKHEVKHL | 571 | Q8TDN4 | |
| DSDLTESLDKHKHKK | 181 | P61566 | |
| VDSDLTESLDKHKHK | 291 | P61570 | |
| TESLDKHKHKKLQSF | 296 | P61570 | |
| VDSDLTESLDKHKHK | 291 | Q69384 | |
| TESLDKHKHKKLQSF | 296 | Q69384 | |
| DSDLTESLDKHKHKK | 181 | P61567 | |
| TSEKHKIHEHLKTSA | 1271 | Q8IWJ2 | |
| DSDLTESLDKHKHKK | 291 | P61565 | |
| DSDLTESLDKHKHKK | 181 | Q9HDB8 | |
| EHKTNLKEKTKAEIH | 76 | Q8TDB4 | |
| VDSDLTESLDKHKHK | 291 | Q902F9 | |
| TESLDKHKHKKLQSF | 296 | Q902F9 | |
| HKVLISKEKSSKAVH | 736 | Q56UN5 | |
| SSKDISKDHLKDIHR | 151 | Q9ULS5 | |
| TSKGKHLLSELKKIH | 2146 | Q8NF91 | |
| EKASILHKIAKKKCH | 381 | Q9UI40 | |
| EKHLNLSAKKKESHL | 146 | A6NI28 | |
| DLLHPSLEEEKKKHK | 6 | Q71UM5 | |
| KSEKKHHCISLKDTN | 306 | Q587J7 | |
| VDEKKLKAHKHSIVI | 26 | Q8TCY5 | |
| HSTPKKEKQERISKH | 571 | Q9H2K8 | |
| ALKAKKAVLKGVHSH | 21 | P62750 | |
| TESTKHKEHKAKTNK | 516 | Q8IX21 | |
| EELDKLSPHKIKHTK | 281 | Q2KHM9 | |
| SSKKKEKRKHVDHVE | 861 | Q96JQ2 | |
| SSTLIKHKKIHTREK | 521 | P35789 | |
| LTEHKKIHTAEKSYK | 371 | Q9UII5 | |
| VTKEHTHNKKEAHKI | 151 | Q5GJ75 | |
| SRHKTKKLSSEKDIH | 81 | Q8NDQ6 | |
| SHHLKKLDVAKKSIK | 306 | Q8NDV3 | |
| DHLTKHKKIHSGEKA | 616 | Q5SVQ8 | |
| SSTLKKHKIIHTGEK | 336 | Q8IYX0 | |
| TEHKKELSKSPEKHF | 136 | Q8NHR7 | |
| SSTLKKHKIVHTGEK | 336 | A6NP11 | |
| STLKKHKIIHTGEKL | 421 | A6NP11 | |
| TKLTRKDCLAKHLKH | 151 | Q9BWV7 | |
| KKEKLSSVDRHHSVE | 501 | Q14151 | |
| HHSVEIKIEKTVIKK | 511 | Q14151 | |
| KHAVKLHLSKTHSKS | 1006 | Q9NRE2 | |
| KDLVKRHHKKTTDLI | 931 | Q9NQ66 | |
| RHHKKTTDLIKEHTT | 936 | Q9NQ66 | |
| SSKLTEHKKLHTGKK | 436 | Q8TD23 | |
| LHTRHTEKLKKSLKV | 116 | A8K0R7 | |
| SNRHKISHTEKKLFK | 161 | P17038 | |
| RSSNLTKHKKIHTEK | 381 | P17038 | |
| KAHLKIHSKEKHASD | 506 | O43167 | |
| THKIIHTKEKPSKSE | 871 | Q05481 | |
| QSSKLTKHKKIHTGE | 521 | Q03923 | |
| FSNLKEHKKTHTADK | 491 | Q6ZSB9 | |
| KKDSVVAHKAKSHPE | 441 | Q96JP5 | |
| KAAKHKAAEVALKHL | 81 | Q15633 | |
| KTALTLHEKTHIEGK | 336 | Q96SR6 | |
| KHKKSHAHTIKLGLV | 451 | P15822 | |
| LSDLTKHKKTHTGEK | 506 | O14628 | |
| SSTLTEHKKIHTRKK | 306 | O75437 | |
| TKHQTKHTAESLKTK | 906 | Q6ZNA1 | |
| FSTLKKHKIIHTGKK | 416 | A6NN14 | |
| IEDKLKKELKHLHHD | 2676 | Q14789 | |
| LKKTEEKKHRTLHTE | 586 | Q5T7N2 | |
| EKKHRTLHTEELTSK | 591 | Q5T7N2 | |
| GHDKVLSILLKHKKA | 626 | P19838 |